Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: relationship to Bcl-2 family and caspase activation

CAS OpenIR > 膜生物学国家重点实验室

	Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: relationship to Bcl-2 family and caspase activation
发表期刊	Oncogene
	2006
卷号	25 期号:58 页码:7618-7634
	Hamai A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
文献类型	期刊论文
条目标识符	http://ir.ioz.ac.cn/handle/000000/10410
专题	膜生物学国家重点实验室
推荐引用方式 GB/T 7714	Hamai A,Richon C,Meslin F,et al. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: relationship to Bcl-2 family and caspase activation[J]. Oncogene,2006,25(58):7618-7634.
APA	Hamai A.,Richon C.,Meslin F.,Faure F.,Kauffmann A.,...&Mehrpour M.(2006).Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: relationship to Bcl-2 family and caspase activation.Oncogene,25(58),7618-7634.
MLA	Hamai A,et al."Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: relationship to Bcl-2 family and caspase activation".Oncogene 25.58(2006):7618-7634.